"UPMC Center for Liver Diseases is a medical clinic located in Pittsburgh, Pa. Visit our website to learn more about the conditions we treat and the services we offer. Schedule your appointment today. UPMC is committed to protecting our communities from the spread of COVID-19. We continue to require people who come to any UPMC facility to wear a facemask that covers their nose and mouth and to practice other preventative efforts like social distancing, even if fully vaccinated."

During the past decade, UPMC Center For Liver Diseases conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 12 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 6 clinical trials were completed. i.e. 85.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UPMC Center For Liver Diseases" #1 sponsor was "Gilead Sciences" with 6 trials, followed by "Bristol-Myers Squibb" with 2 trials sponsored, "Enanta Pharmaceuticals, Inc" with 2 trials sponsored, "Axcella Health, Inc" with 1 trials sponsored and "Calliditas Therapeutics AB" with 1 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UPMC Center For Liver Diseases" #1 collaborator was "ICON Clinical Research" with 1 trials as a collaborator, "Registrat-Mapi" with 1 trials as a collaborator and "Triangle Biostatistics" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "UPMC Center For Liver Diseases" are "Hepatitis C" (3 trials), "Non-Alcoholic Steatohepatitis" (3 trials), "Hepatitis C Virus Infection" (2 trials), "Hepatitis C, Chronic" (2 trials) and "NASH - Nonalcoholic Steatohepatitis" (2 trials). Many other conditions were trialed in "UPMC Center For Liver Diseases" in a lesser frequency.

Most popular intervention types in "UPMC Center For Liver Diseases" are "Drug" (17 trials), "Behavioral" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "RBV" (3 trials), "JNJ-56136379" (2 trials), "SOF/VEL" (2 trials) and "VOX" (2 trials). Other intervention names were less common.

The vast majority of trials in "UPMC Center For Liver Diseases" are 23 trials for "All" genders.

Currently, there are NaN active trials in "UPMC Center For Liver Diseases". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in UPMC Center For Liver Diseases, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in UPMC Center For Liver Diseases, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".